Clinical trial Recruiting at 1 site Interventional Ages 5 to 13

Modified constraint-induced movement therapy with or without proprioceptive neuromuscular facilitation for children after stroke

Official title: Effects of Modified Constraint-induced Movement Therapy With and Without Proprioceptive Neuromuscular Facilitation Techniques on Upper Extremity Function in Pediatric Stroke Patients

Run by Riphah International University · NCT07244042 · Data updated 2026-11-12

We will test whether adding PNF techniques to modified CIMT helps improve arm and hand function in children aged 5–13 who had a stroke.

Quick facts

Study typeInterventional
Ages5 Years to 13 Years
SexAll
Enrollment20 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedOctober 27, 2025
Main results expectedJanuary 25, 2026
Study endsFebruary 10, 2026
Registry record updatedNovember 24, 2025
Trial IDNCT07244042 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 5–13 with confirmed pediatric stroke, MAS spasticity level 1–2, MACS scores in the specified range, GMFCS level 1–2, and minimum active wrist and finger extension as listed are ideal candidates.

Probably not a fit

Children with uncontrolled seizures, recent botulinum toxin treatment, cognitive impairment, recent fractures, or recent upper-extremity surgery are excluded and are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial will enroll 20 children with pediatric stroke and upper-extremity impairments, randomly assigning them to six weeks of modified constraint-induced movement therapy (CIMT) alone or CIMT combined with proprioceptive neuromuscular facilitation (PNF). Therapists will deliver the interventions and participants will be evaluated before and after the intervention using standardized measures including the Pediatric Motor Activity Log (PMAL), Modified Ashworth Scale (MAS), and Manual Ability Classification System (MACS), along with measures of muscle tone and physical activity. Data will be entered and analyzed in SPSS v26.0 to compare changes between the two groups. The protocol excludes children with epilepsy, recent botulinum toxin injections, cognitive impairment, recent fractures, or recent upper-extremity surgery.

Why it matters

Potential benefit: If successful, combining PNF with modified CIMT could produce greater improvements in arm and hand movement and help children regain more independence in daily activities.

How similar studies have gone: CIMT has demonstrated benefits for upper-limb recovery in children after stroke, while the combination of CIMT and PNF is less well studied and represents a relatively novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Paeds Patients with confirmed diagnosis of Stroke
* Children between age 5 to 13 years
* Modified Ashworth Scale spasticity level 1 and 2.
* Patients having Manual Ability Classification System Score between 3 to 6.
* GMFCS level 1 and 2
* Patient having in affected upper extremity at least 20◦ of active wrist extension starting from the full flexion, 10◦ of active extension or abduction in the thumb, and 10◦ of active extension in the metacarpophalangeal and interphalangeal joints of the other fingers

Exclusion Criteria:

* Patients with epilepsy or seizure disorder
* Patients with history of botulinum toxin injection, cognitive impairment, fracture and any surgical procedure in upper extremity

Where it's running

  • Imran Amjad
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.